TY - JOUR
T1 - Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis
T2 - the European Scleroderma Observational Study
AU - Peytrignet, Sébastien
AU - Denton, Christopher P
AU - Lunt, Mark
AU - Hesselstrand, Roger
AU - Mouthon, Luc
AU - Silman, Alan
AU - Pan, Xiaoyan
AU - Brown, Edith
AU - Czirják, László
AU - Distler, Jörg H W
AU - Distler, Oliver
AU - Fligelstone, Kim
AU - Gregory, William J
AU - Ochiel, Rachel
AU - Vonk, Madelon
AU - Ancuta, Codrina
AU - Ong, Voon H
AU - Farge, Dominique
AU - Hudson, Marie
AU - Matucci-Cerinic, Marco
AU - Balbir-Gurman, Alexandra
AU - Midtvedt, Øyvind
AU - Jordan, Alison C
AU - Stevens, Wendy
AU - Moinzadeh, Pia
AU - Hall, Frances C
AU - Agard, Christian
AU - Anderson, Marina E
AU - Diot, Elisabeth
AU - Madhok, Rajan
AU - Akil, Mohammed
AU - Buch, Maya H
AU - Chung, Lorinda
AU - Damjanov, Nemanja
AU - Gunawardena, Harsha
AU - Lanyon, Peter
AU - Ahmad, Yasmeen
AU - Chakravarty, Kuntal
AU - Jacobsen, Søren
AU - MacGregor, Alexander J
AU - McHugh, Neil
AU - Müller-Ladner, Ulf
AU - Riemekasten, Gabriela
AU - Becker, Michael
AU - Roddy, Janet
AU - Carreira, Patricia E
AU - Fauchais, Anne Laure
AU - Hachulla, Eric
AU - Hamilton, Jennifer
AU - Inanç, Murat
AU - McLaren, John S
AU - van Laar, Jacob M
AU - Pathare, Sanjay
AU - Proudman, Susanna
AU - Rudin, Anna
AU - Sahhar, Joanne
AU - Coppere, Brigitte
AU - Serratrice, Christine
AU - Sheeran, Tom
AU - Veale, Douglas J
AU - Grange, Claire
AU - Trad, Georges-Selim
AU - Herrick, Ariane L
N1 - © The Author 2017. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: [email protected]
PY - 2018/2/1
Y1 - 2018/2/1
N2 - Objectives. Our aim was to describe the burden of early dcSSc in terms of disability, fatigue and pain in the European Scleroderma Observational Study cohort, and to explore associated clinical features. Methods. Patients completed questionnaires at study entry, 12 and 24 months, including the HAQ disability index (HAQ-DI), the Cochin Hand Function Scale (CHFS), the Functional Assessment of Chronic Illness Therapy-fatigue and the Short Form 36 (SF36). Associates examined included the modified Rodnan skin score (mRSS), current digital ulcers and internal organ involvement. Correlations between 12-month changes were also examined. Results. The 326 patients recruited (median disease duration 11.9 months) displayed high levels of disability [mean (S.D.) HAQ-DI 1.1 (0.83)], with 'grip' and 'activity' being most affected. Of the 18 activities assessed in the CHFS, those involving fine finger movements were most affected. High HAQ-DI and CHFS scores were both associated with high mRSS (r = 0.34, P < 0.0001 and r = 0.35, P < 0.0001, respectively). HAQ-DI was higher in patients with digital ulcers (P = 0.004), pulmonary fibrosis (P = 0.005), cardiac (P = 0.005) and muscle involvement (P = 0.002). As anticipated, HAQ-DI, CHFS, the Functional Assessment of Chronic Illness Therapy and SF36 scores were all highly correlated, in particular the HAQ-DI with the CHFS (ρ = 0.84, P < 0.0001). Worsening HAQ-DI over 12 months was strongly associated with increasing mRSS (ρ = 0.40, P < 0.0001), decreasing hand function (ρ = 0.57, P < 0.0001) and increasing fatigue (ρ =-0.53, P < 0.0001). Conclusion. The European Scleroderma Observational Study highlights the burden of disability in early dcSSc, with high levels of disability and fatigue, associating with the degree of skin thickening (mRSS). Impaired hand function is a major contributor to overall disability.
AB - Objectives. Our aim was to describe the burden of early dcSSc in terms of disability, fatigue and pain in the European Scleroderma Observational Study cohort, and to explore associated clinical features. Methods. Patients completed questionnaires at study entry, 12 and 24 months, including the HAQ disability index (HAQ-DI), the Cochin Hand Function Scale (CHFS), the Functional Assessment of Chronic Illness Therapy-fatigue and the Short Form 36 (SF36). Associates examined included the modified Rodnan skin score (mRSS), current digital ulcers and internal organ involvement. Correlations between 12-month changes were also examined. Results. The 326 patients recruited (median disease duration 11.9 months) displayed high levels of disability [mean (S.D.) HAQ-DI 1.1 (0.83)], with 'grip' and 'activity' being most affected. Of the 18 activities assessed in the CHFS, those involving fine finger movements were most affected. High HAQ-DI and CHFS scores were both associated with high mRSS (r = 0.34, P < 0.0001 and r = 0.35, P < 0.0001, respectively). HAQ-DI was higher in patients with digital ulcers (P = 0.004), pulmonary fibrosis (P = 0.005), cardiac (P = 0.005) and muscle involvement (P = 0.002). As anticipated, HAQ-DI, CHFS, the Functional Assessment of Chronic Illness Therapy and SF36 scores were all highly correlated, in particular the HAQ-DI with the CHFS (ρ = 0.84, P < 0.0001). Worsening HAQ-DI over 12 months was strongly associated with increasing mRSS (ρ = 0.40, P < 0.0001), decreasing hand function (ρ = 0.57, P < 0.0001) and increasing fatigue (ρ =-0.53, P < 0.0001). Conclusion. The European Scleroderma Observational Study highlights the burden of disability in early dcSSc, with high levels of disability and fatigue, associating with the degree of skin thickening (mRSS). Impaired hand function is a major contributor to overall disability.
KW - Adult
KW - Cost of Illness
KW - Disability Evaluation
KW - Europe
KW - Fatigue/etiology
KW - Female
KW - Fingers
KW - Hand Strength
KW - Health Surveys
KW - Humans
KW - Male
KW - Pain/etiology
KW - Prospective Studies
KW - Scleroderma, Diffuse/complications
KW - Severity of Illness Index
KW - Skin Ulcer/etiology
U2 - 10.1093/rheumatology/kex410
DO - 10.1093/rheumatology/kex410
M3 - Journal article
C2 - 29207002
SN - 1462-0324
VL - 57
SP - 370
EP - 381
JO - Rheumatology
JF - Rheumatology
IS - 2
ER -